These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT. Kim HO, Kim JS, Shin YM, Ryu JS, Lee YS, Lee SG. J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794 [Abstract] [Full Text] [Related]
4. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors. Song JY, Lee YN, Kim YS, Kim SG, Jin SJ, Park JM, Choi GS, Chung JC, Lee MH, Cho YH, Choi MH, Kim DC, Choi HJ, Moon JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS. Nucl Med Commun; 2015 Apr; 36(4):319-27. PubMed ID: 25564069 [Abstract] [Full Text] [Related]
5. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer. Risse JH, Pauleit D, Bender H, Rabe C, Fischer HP, Biersack HJ, Bucerius J. Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579 [Abstract] [Full Text] [Related]
6. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Kubo S, Ochi H. Am J Gastroenterol; 2001 Jun; 96(6):1877-80. PubMed ID: 11419843 [Abstract] [Full Text] [Related]
9. Value of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACE. Song HJ, Cheng JY, Hu SL, Zhang GY, Fu Y, Zhang YJ. Clin Radiol; 2015 Feb; 70(2):128-37. PubMed ID: 25459673 [Abstract] [Full Text] [Related]
12. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Wolfort RM, Papillion PW, Turnage RH, Lillien DL, Ramaswamy MR, Zibari GB. Int Surg; 2010 Feb; 95(1):67-75. PubMed ID: 20480845 [Abstract] [Full Text] [Related]
13. [Malignant tumor with false negative 18F-FDG PET image]. Dong MJ, Lin XT, Zhao J, Guan YH, Zuo CT, Chen X, Dai JZ, Jiang BD. Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383 [Abstract] [Full Text] [Related]
16. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma. Wang XL, Li H, Wang QS, Zhang XL. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890 [Abstract] [Full Text] [Related]
20. [18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]. Shang JB, Li YH, Liu FY, Zeng QL, Wang JY, He XF, Chen Y. Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):697-9. PubMed ID: 15201094 [Abstract] [Full Text] [Related] Page: [Next] [New Search]